A detailed history of Csenge Advisory Group transactions in Mckesson Corp stock. As of the latest transaction made, Csenge Advisory Group holds 2,416 shares of MCK stock, worth $1.51 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,416
Previous 2,396 0.83%
Holding current value
$1.51 Million
Previous $1.4 Million 14.65%
% of portfolio
0.06%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$479.06 - $630.38 $9,581 - $12,607
20 Added 0.83%
2,416 $1.19 Million
Q2 2024

Jul 10, 2024

BUY
$518.81 - $607.81 $73,671 - $86,309
142 Added 6.3%
2,396 $1.4 Million
Q1 2024

May 03, 2024

SELL
$473.42 - $539.26 $53,496 - $60,936
-113 Reduced 4.77%
2,254 $1.21 Million
Q4 2023

Feb 13, 2024

BUY
$437.42 - $470.64 $93,607 - $100,716
214 Added 9.94%
2,367 $1.1 Million
Q3 2023

Nov 01, 2023

SELL
$402.4 - $446.42 $9,255 - $10,267
-23 Reduced 1.06%
2,153 $936,000
Q2 2023

Jul 20, 2023

BUY
$354.01 - $427.31 $140,895 - $170,069
398 Added 22.38%
2,176 $929,000
Q1 2023

May 01, 2023

SELL
$335.35 - $386.06 $69,417 - $79,914
-207 Reduced 10.43%
1,778 $633,000
Q4 2022

Feb 10, 2023

SELL
$346.68 - $397.58 $172,993 - $198,392
-499 Reduced 20.09%
1,985 $744,000
Q3 2022

Oct 04, 2022

BUY
$321.25 - $373.84 $32,767 - $38,131
102 Added 4.28%
2,484 $844,000
Q2 2022

Jul 27, 2022

BUY
$300.57 - $336.42 $146,077 - $163,500
486 Added 25.63%
2,382 $777,000
Q1 2022

May 09, 2022

BUY
$244.61 - $310.48 $463,780 - $588,670
1,896 New
1,896 $581,000
Q4 2018

Feb 07, 2019

SELL
$108.23 - $136.84 $3,788 - $4,789
-35 Closed
0 $0
Q3 2018

Nov 19, 2018

BUY
$123.14 - $138.52 $4,309 - $4,848
35 New
35 $4,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $89.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.